Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-[4-(dimethylamino)phenyl]-6-[(6-morpholin-4-ylpyridin-3-yl)ethynyl]pyrimidin-4-amine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the class of dialkylarylamines and aromatic heteromonocyclic compounds. It features a pyrimidine core substituted with a dimethylaminophenyl group and an ethynyl-linked morpholinopyridin moiety. The compound is primarily used as an experimental research tool, notably in screening assays for kinase inhibition and related biochemical studies. There is no evidence it has been developed or approved for clinical use in humans, nor are there any known therapeutic indications or marketed formulations[1][3]. Its mechanism of action, specific biological targets, and pharmacological properties have not been fully characterized in public sources.
- Other names
- 5-(4-(Dimethylamino)phenyl)-6-((6-morpholin-4-ylpyridin-3-YL)ethynyl)pyrimidin-4-amine
02
Targets
AXL (AXL receptor tyrosine kinase)
Beyond the preview
Go deeper on 5-[4-(dimethylamino)phenyl]-6-[(6-morpholin-4-ylpyridin-3-yl)ethynyl]pyrimidin-4-amine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-[4-(dimethylamino)phenyl]-6-[(6-morpholin-4-ylpyridin-3-yl)ethynyl]pyrimidin-4-amine.